[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 18.206.12.79. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 437
Citations 0
Editorial
January 9, 2020

Minimizing Excess Opioid Prescribing for Acute Postoperative Pain

Author Affiliations
  • 1Department of Otolaryngology–Head and Neck Surgery, Wayne State University School of Medicine, Detroit, Michigan
  • 2Department of Otolaryngology–Head and Neck Surgery, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York
  • 3Department of Otolaryngology–Head and Neck Surgery, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
  • 4UPMC Children’s Hospital of Pittsburgh, Pittsburgh, Pennsylvania
  • 5Department of Otolaryngology–Head and Neck Surgery, University of Illinois College of Medicine, Chicago
  • 6Associate Editor, JAMA Otolaryngology-Head & Neck Surgery
JAMA Otolaryngol Head Neck Surg. Published online January 9, 2020. doi:10.1001/jamaoto.2019.4209

The United States is struggling with an epidemic of opioid abuse driven in part by postoperative opioid prescribing patterns. Opioid prescribing after surgery is one of the most common methods of initial opioid exposure and places patients at risk of developing opioid dependency. In otolaryngology, 6% of the patients who are opioid-naive develop postoperative iatrogenic opioid dependency,1 which contributes considerably to the epidemic because approximately 16 million otolaryngology operations are performed each year globally.2

Limit 200 characters
Limit 25 characters
Conflicts of Interest Disclosure

Identify all potential conflicts of interest that might be relevant to your comment.

Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.

Err on the side of full disclosure.

If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.

Not all submitted comments are published. Please see our commenting policy for details.

Limit 140 characters
Limit 3600 characters or approximately 600 words
    ×